Asbestos legislation has been stuck in a congressional black hole since early last year when the Fairness in Asbestos Injury Resolution Act was presented to the House of Representatives. The bill sought to establish a $140 billion national trust fund to handle claims related to the known carcinogen, but since it appeared, the bill moved to the Senate where much posturing but little action has occurred until recently.
The FAIR Act would create a privately funded, publicly administered trust fund that would provide compensation for legitimate present and future claimants of asbestos exposure. It would be paid for by defendant participants and insurers, with the latter contributing over $45 billion over the next two and a half decades. Its creation, however, would prevent the courts from hearing lawsuits from those claiming to be affected by the fibrous material, which could significantly limit some companies' liabilities.
For instance, U.S. Gypsum recently announced it had settled the claims made against it in regards to employees who were exposed to asbestos. The company agreed to establish its own personal injury trust fund that initially would be funded with $900 million dollars, with an additional $3.05 billion promised by the company as a contingent note. The contingency? If FAIR is approved by Congress, the company will only be required to pay the initial $900 million.
Recommended For You
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.